- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Residiverende og refraktært myelomatose in United States
Totalt 29546 resultater
-
Novartis PharmaceuticalsFullførtRefraktært myelomatose | Myelomatose i tilbakefall | Tilbakefall og Bortezomib Refractory Multiple MyelomaForente stater
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncAvsluttetRefraktært myelomatose | Myelom | Myelom multippelForente stater
-
National Cancer Institute (NCI)AvsluttetMyelom, multippel | Myelom-multippelForente stater
-
Michael A. Thompson, MD, PhDVince Lombardi Cancer ClinicFullførtMultippelt myelom | Myelom, multippel | Myelom-multippelForente stater
-
US Oncology ResearchKaryopharm Therapeutics IncRekrutteringMultippelt myelom | Plasmacellemyelom | Myelom-multippel | Myelom multippel | Kahlers sykdom | Myelom, plasmacelle | MyelomatoseForente stater
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)FullførtMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)FullførtMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)Georgetown University; Hackensack Meridian HealthAvsluttetMyelom-multippel | Myelom, plasmacelle | MyelomatoseForente stater
-
Cartesian TherapeuticsRekrutteringMyelom multippelForente stater
-
Cartesian TherapeuticsFullførtMyelom multippelForente stater
-
AmgenAktiv, ikke rekrutterendeResidiverende eller refraktært myelomatose | Tilbakefallende eller refraktær akutt myeloid leukemiForente stater, Australia, Japan, Tyskland, Canada
-
University of LeedsKaryopharm Therapeutics Inc; Myeloma UKTilbaketrukketPembrolizumab cyklofosfamid og lenalidomid for pasienter med residiverende myelomatose (MUKfourteen)Myelom multippelStorbritannia
-
K36 Therapeutics, Inc.RekrutteringMultippelt myelom | Myelom | Myelom multippelForente stater, Frankrike, Spania, Canada
-
University of NebraskaM.D. Anderson Cancer CenterAvsluttetMultippelt myelom | Refraktært myelomatose | Residiverende/refraktært myelomatoseForente stater
-
M.D. Anderson Cancer CenterRekruttering
-
Novartis PharmaceuticalsFullførtMultippel myelom beinsykdomStorbritannia, Forente stater
-
Alfred Chung, MDMerck Sharp & Dohme LLCAvsluttetMultippelt myelom | Refraktært plasmacellemyelom | Tilbakevendende plasmacellemyelom | Myelomatose i tilbakefall | Myelomatose, refraktærtForente stater
-
Abramson Cancer Center at Penn MedicineRekruttering
-
UNC Lineberger Comprehensive Cancer CenterConquer Cancer FoundationFullførtMultippelt myelom | Myelom | Funksjonshemming Fysisk | Funksjonshemminger MultipleForente stater
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyFullførtResidiverende eller refraktært myelomatose | Tilbakefallende eller refraktær akutt myeloid leukemi | Tilbakefallende eller refraktær non-Hodgkin lymfom | Tilbakefallende eller refraktær kronisk lymfatisk leukemiStorbritannia, Spania, Frankrike, Australia
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationAktiv, ikke rekrutterende
-
Carl Ola Landgren, MD, PhDBristol-Myers SquibbRekrutteringRefraktært myelomatose | Tilbakefallende myelomatoseForente stater
-
Opna Bio LLCHar ikke rekruttert ennåRefraktært myelomatose | Tilbakefallende myelomatoseForente stater
-
Cartesian TherapeuticsRekrutteringRefraktært myelomatose | Tilbakefallende myelomatoseForente stater
-
Thomas Martin, MDBristol-Myers Squibb; Janssen Research & Development, LLCHar ikke rekruttert ennåMultippelt myelom | Refraktært myelomatose | Tilbakefallende myelomatoseForente stater
-
Thomas Martin, MDUniversity of California, Davis; Actavis Inc.; Eugia Pharma Specialities...Aktiv, ikke rekrutterendeRefraktært myelomatose | Tilbakefallende myelomatoseForente stater
-
Andrew Yee, MDBristol-Myers Squibb; Takeda Pharmaceuticals North America, Inc.AvsluttetRefraktært myelomatose | Tilbakefallende myelomatoseForente stater
-
Massachusetts General HospitalPfizerRekrutteringMultippelt myelom | Refraktært myelomatose | Tilbakefall myelomatoseForente stater
-
Medical College of WisconsinRekrutteringRefraktært myelomatose | Tilbakefall myelomatoseForente stater
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRekrutteringMultippelt myelom | Refraktært myelomatose | Tilbakefall myelomatoseForente stater
-
Ajai ChariAmgenFullførtRefraktært myelomatose | Tilbakefall myelomatoseForente stater
-
All4CureGlaxoSmithKlineRekrutteringMultippelt myelom | Myelomatose i tilbakefall | Myelomatose med mislykket remisjon | Myelomatose, refraktærtForente stater
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)AvsluttetStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
National Cancer Institute (NCI)AvsluttetStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
National Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
City of Hope Medical CenterFullførtPlerixafor og Filgrastim etter cyklofosfamid for stamcellemobilisering hos pasienter med myelomatoseStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityAvsluttetPrimær myelofibrose | Anemi | Tilbakevendende Hodgkin-lymfom | Refraktært Hodgkin-lymfom | Anatomisk stadium IV brystkreft AJCC v8 | Tilbakevendende akutt myeloid leukemi | Tilbakevendende myelodysplastisk syndrom | Refraktær Akutt Myeloid Leukemi | Refraktær kronisk myelomonocytisk leukemi | Refraktært myelodysplastisk... og andre forholdForente stater
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
National Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
National Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
Luminary TherapeuticsThe Cleveland Clinic; Case Western Reserve UniversityRekrutteringMyelomatose i tilbakefall | Myelomatose, refraktærtForente stater
-
Ajai ChariCelgene CorporationFullførtMyelomatose i tilbakefall | Myelomatose, refraktærtForente stater
-
University of WashingtonNational Cancer Institute (NCI)AvsluttetStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)AvsluttetStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
National Cancer Institute (NCI)FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom | Refraktært myelomatoseForente stater
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Genus Oncology, LLCTilbaketrukketMultippelt myelom | Refraktært myelomatose | Myelomatose i tilbakefallForente stater
-
Gadeta B.V.Aktiv, ikke rekrutterendeMultippelt myelom | Myelomatose i tilbakefall | Myelomatose, refraktærtForente stater